Advertisement

New Study in JCO Oncology Practice Highlights Smoking Cessation Initiative Success for Patients With Cancer


Advertisement
Get Permission

A new study in JCO Oncology Practice (JCO OP) highlights an effective effort to increase the use of evidence-based state smoking cessation programs among patients with cancer and survivors who use tobacco.

In Michigan, state agencies and the Michigan Oncology Quality Consortium partnered to create and implement a program that would provide patients with the tools and resources to help them quit smoking after a cancer diagnosis. The collaboratively designed program—the Michigan Tobacco Quitline (Quitline)—uses an opt-out approach to refer tobacco users to existing state smoking cessation resources.  

Between 2012 and 2017, 4,347 patients with cancer enrolled in the Quitline, and during this time, oncology practice referrals to state smoking cessation resources increased from 5% to 17%. This significant increase led to a 26% quit rate for patients with cancer. The Michigan Behavioral Risk Factor Surveillance System also saw an increase in smoking cessation in cancer survivors from 60% to 80% between 2013 and 2016.

The JCO OP study comes following the latest Surgeon General’s report—the office’s first report on smoking cessation in 30 years—which suggested that quitting smoking lowers mortality rates for smokers who are diagnosed with cancer.

Quitline also demonstrates how a collaborative initiative to promote existing resources can be a cost-effective way to serve patients in an increasingly expensive health-care environment.

Read the full study in JCO OP.

Visit ASCO in Action for updates on this issue and breaking cancer policy news.  

© 2020. American Society of Clinical Oncology. All rights reserved.

 


Advertisement

Advertisement



Advertisement